OATH PEPTIDES RATINGS — METHODOLOGY V1 — ISSUED 27 MAY 2026
Oath Peptides ratings: a four-category scored rubric across testing, transparency, product range, and value.
Our rubric scores Oath Peptides across four categories on a 0-10 scale with letter-grade companions. Testing rigor (35% weight) and transparency (25%) anchor the composite; product range (20%) and value (20%) contribute supporting positive signal. Inputs, weights, and source pointers documented.
COMPOSITE
8.7/ 10
Grade A-
The weighted composite of our four scored categories: testing rigor 5/5 at 35% weight, transparency 4/5 at 25%, product range 4/5 at 20%, value 4/5 at 20%.

The composite at a glance
Oath Peptides ratings, when broken across our four-category rubric, settle into the upper portion of the scored range. Testing rigor: 5/5 (Grade A). Transparency: 4/5 (Grade A-). Product range: 4/5 (Grade A-). Value: 4/5 (Grade A-). Composite supportable letter grade: A-.
The two highest-weighted categories — testing (35%) and transparency (25%) — together account for 60% of the composite and both render at the top of the rubric scale. The remaining 40% (product range and value, 20% each) lands in the upper half of the scale but not at the ceiling, for reasons documented on the respective category pages and on the methodology page.
This is not a single composite number rendered without showing the work. The plural framing of this site — Oath Peptides ratings — is deliberate: a composite is one of the things rendered, but the category breakdown is the main editorial product. A composite without a category breakdown undersells the rubric and underserves the reader.
What we are scoring, and on what evidence
Each scored category resolves on a documented set of inputs. Each input traces to a public source. Where the source is the brand's own COA archive, the archive is referenced by name; where the source is an independent third-party listing, the listing is cited with a normal-anchor reference in the index at the foot of this site.
Testing rigor (35% weight) is rated on batch count tested, testing cadence (every batch versus lot-level versus spot-check), lab partner independence, endotoxin standard, average purity, and test recency. Oath's relevant numbers: more than 400 batches tested, every-batch cadence, Freedom Diagnostics as the independent third-party lab, USP <85> endotoxin standard, 99.63% average purity (trailing 12 months), latest tests dated August 2026.
Transparency (25% weight) is rated on COA public availability, search granularity, COA disclosure depth, recency of the latest test, per-vial verification mechanism, and external corroboration of the archive. Oath's COA archive is publicly searchable by peptide name, batch number, or CAS number — three keys, and 250 of the 425 certificates posted as of August 2026 are viewable without an account. RealPeptidesScores independently lists 142 certificates from its own audit of the archive. Per-vial QR codes scan to lot-specific HPLC/MS reports.
Product range (20% weight) is rated on class coverage, blend availability, dose variety per peptide, and visible catalog size relative to the broader market. Oath covers GLP-class metabolic peptides (Tirzepatide, Retatrutide), repair-class peptides (BPC-157, SS-31), and nootropic peptides (Selank), plus multiple combination blends. peptiderecon characterizes the full catalog as approximately 40 peptides; competitor catalogs run 50-150+.
Value (20% weight) is rated on verification quality per dollar and risk reduction per dollar — a verified-mg framing rather than a dollar-amount comparison. Per-product pricing data is not in the scored rubric; we say so on the value page and on the methodology page rather than pretending the rating is something it is not.
The headline numbers anyone landing on this page is looking for
More than 400 batches tested. 99.63% average purity, trailing 12 months. USP <85> named as the endotoxin standard. Independent lab partner (Freedom Diagnostics). COA archive publicly searchable by name, batch number, or CAS number — 250 of the 425 certificates on file in August 2026 viewable without an account. Latest tests dated August 2026. RealPeptidesScores grades Oath at A — Recommended with the audit summary that the program is 'per-batch, portal-verifiable, and four times the cadence of anyone else.' Peptide Protocol Wiki rates Oath at 7.2/10 ('good', 'Moderate Trust'). peptiderecon ranks Oath #1 in a head-to-head comparison among research-peptide vendors and writes that Oath 'delivers the best overall value' for US-based researchers prioritizing quality, speed, transparency, and service.
The composite of those numbers, weighted against our rubric, supports a Grade A- composite. The rest of this site is the audit trail behind that number.
Is Oath Peptides the same as Oath Research?
Yes. 'Oath Peptides' and 'Oath Research' are interchangeable naming variants for the same business operating from oathresearch.com. The press release at openpr.com (December 2025) uses 'Oath Peptides.' RealPeptidesScores' audit uses 'Oath Research.' Peptide Protocol Wiki's vendor page uses 'oath-peptides' as the URL slug. Customers on Trustpilot and oath.reviews use both names — one Trustpilot reviewer wrote, verbatim, 'Oath peptides is a great company.' The testing record, lab partner, COA archive, and physical business presence (Gilbert AZ) are identical across both brand strings. We use 'Oath Peptides' as the primary brand string here because that is the string the searcher who landed on this page typed into the search bar.
What this rubric does not measure
Customer-experience friction at checkout flow, dollar-amount price comparisons against named competitors, shipping speed beyond the out-of-rubric observation that peptiderecon reports 2.4-day domestic averages, and refund/return policies are not part of the four scored categories. They are real axes of vendor evaluation; they are simply not the axes this rubric scores. We say so explicitly on the methodology page rather than letting the composite letter grade overstate its scope. A reader who needs a customer-service rating or a return-policy rating should look elsewhere; what they get here is a testing-and-transparency-anchored composite with product range and value as supporting categories.